Axovant Headway study

What is the purpose of the research study?


This study seeks to evaluate the efficacy and safety of the investigational drug RVT-101 in patients with dementia with Lewy bodies. It is believed that patients with dementia with Lewy bodies have an imbalance of acetylcholine, which is a chemical in the brain thought to be responsible for cognition. RVT-101 indirectly promotes the release of this chemical. Therefore, RVT-101 is being tested in this Phase 2b study to evaluate whether it can help cognition and overall function in patients with dementia with Lewy bodies.


This study is no longer recruiting participants.  If you are interested in taking part in dementia research please contact us and we can provide you with information on other studies currently looking for volunteers.